Business
Merck drug less effective against moderate COVID -India regulatory source – Reuters
Merck & Co’s (MRK.N) experimental antiviral drug molnupiravir has not shown “significant efficacy” against moderate COVID-19,…
The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermidNEW DELHI, Oct 8 (Reuters) – Merck & Co’s (MRK.N) experimental antiviral drug molnupiravir has not shown “significant efficacy”…
Continue Reading
-
General9 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News18 hours agoRainbow Beach surfer’s untold 7/7 story
-
Noosa News11 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland
-
General23 hours agoWest Indies vs Australia live: Second Test, day three from Grenada